| Catalog Number |
309658 |
| Medical Device Problem Code |
Contamination (1120)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/09/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that bd syringe 3ml ll euro 200 s/c contained foreign matter.A clinical trial site has noted that there are black blemishes/spots visible on or in bd syringes.Please see attached picture evidence.Confirmed products and lot numbers so far that are confirmed are below: bd 1ml syringes, lot: 4354445, expiry: 2029-11-30, bd 3ml syringes, lot: 4352796, expiry: 2029-11-30, bd 3ml syringes, lot: 5072741, expiry: 2030-02-28.Out client noted the blemishes/ black spots on (b)(6) 2026.Fcs were informed on the 26th january.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4) follow up: two photos were received showing three loose, fully assembled 3 ml ll syringes part number 309658 with printing defects.In the first photo, one syringe is partially missing the bd logo and two ink dots on the barrel.The second photo shows three syringes with one or more unintended ink dots in the non-scale marking area.These conditions are non-conforming to product specifications, and the missing print and ink dot defects are likely associated with the marking process.A device history record review was completed for material number 309658, lots 4352796 and 5072741.All in process and final visual inspections were performed as required, and no quality notifications related to the reported condition were identified.The lots met acceptance criteria per the inspection control plan, were approved for shipment, and are in compliance with applicable product specifications.
|
| |
|
Search Alerts/Recalls
|